ARUP Newsroom

Updated ARUP Consult® resources on hematologic malignancies describe how laboratory tests can be used in the diagnosis, prognosis, treatment, and management of these diseases.

A new ARUP Consult® topic on testing for preeclampsia, which can be difficult to diagnose, distills guidelines from several sources to help clinicians order the right test at the right time.

ARUP has been awarded a CDC contract for avian influenza A (H5N1) test development, which recognizes our expertise and experience with assay development and our desire to serve public health needs.

Fraudsters are reportedly posing as ARUP recruiters, offering remote work and sending fake onboarding materials, including fraudulent tax documents, to obtain job seekers’ financial information.

Medical Director Ryan Nelson, PharmD, will moderate a STRIPE Annual Meeting workshop in October focused on building consensus around standards for integrating personalized medicine into healthcare.

Susan Driggs, a medical laboratory scientist in ARUP’s University of Utah Hospital Clinical Laboratory, has worked in the same lab since before ARUP’s inception in 1984.

A new, first-of-its-kind test uses blood-based biomarkers to assess the risk of developing preeclampsia with severe features and facilitates appropriate interventions.

ARUP has been working on a bird flu testing solution for more than a year and is prepared to scale up capacity quickly should the need arise.